AMN Healthcare Services Inc. (AMN) saw its stock price plummet 7.51% in after-hours trading on Thursday, following the release of its disappointing second-quarter 2025 financial results. The healthcare staffing company reported a significant net loss and a double-digit decline in revenue, falling short of investor expectations despite beating some analyst estimates.

For Q2 2025, AMN Healthcare posted a revenue of $658 million, representing an 11% decrease compared to the same period last year. The company reported a net loss of $116 million, or ($3.02) per diluted share, a stark contrast to the net income of $16 million, or $0.42 per diluted share, in Q2 2024. Adjusted diluted earnings per share (EPS) came in at $0.30, marking a 69% drop from $0.98 in the prior-year quarter. The Nurse and Allied Solutions segment, a key revenue driver, saw a 14% year-over-year decline to $382 million.

Despite the overall negative results, there were some bright spots in AMN's report. The company's allied staffing business exceeded revenue projections for the quarter, and its AMN Passport app for healthcare professionals surpassed 300,000 users. Looking ahead, AMN anticipates a gain of approximately $40 million from the sale of Smart Square in the third quarter. The company also noted signs of improvement in July, with stabilizing orders and rebounding extension rates, suggesting potential recovery in the coming months.